Investors & Media Home

Download Mesoblast Corporate Backgrounder

Mesoblast Corporate Backgrounder (350 KB)

Mesoblast is a world leader in developing innovative cellular medicines.

The Company has established what it believes is the industry's most clinically advanced and diverse portfolio of cell-based product candidates ... More

Latest ASX AnnouncementsMore
20 September 2018
Day 180 Survival Outcomes In aGvHD Phase 3 Trial
... 
17 September 2018
Tasly Receives Approvals For Transaction With MSB
... 
30 August 2018
Mesoblast Reports on Annual and Fourth Quarter Results
... 
30 August 2018
Annual Financial Results Presentation
... 
Upcoming EventsMore
There are currently no events scheduled.
Stock QuoteMore
Exchange :ASX
Price :A$1.83
Change : Stock is Down 0.04 (2.14%)
Volume :990,767
Data as of 24 September 2018 4:10 p.m. ET
Data provided by Nasdaq Minimum 15 minutes delay
Download Documentation Financial Results for the 2018 Full Financial Year, 4th Quarter Ended June 30, 2018
Download Documentation Financial Results for the Period Ended September 30, 2017
Download Documentation 2017 Annual Report
Download Documentation Financial Results for the Three Months and for the Year Ended June 30, 2017
E-mail Alerts
Sign up to receive e-mail alerts.

Share Price ASX: MSB  AUD 1.83 as of Sep 24, 2018